Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesCurrent TaxesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsOperating LeasesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Retained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Medifast (MED) Total Current Liabilities (2016 - 2025)

Historic Total Current Liabilities for Medifast (MED) over the last 16 years, with Q4 2025 value amounting to $43.0 million.

  • Medifast's Total Current Liabilities fell 3304.03% to $43.0 million in Q4 2025 from the same period last year, while for Dec 2025 it was $43.0 million, marking a year-over-year decrease of 3304.03%. This contributed to the annual value of $43.0 million for FY2025, which is 3304.03% down from last year.
  • Latest data reveals that Medifast reported Total Current Liabilities of $43.0 million as of Q4 2025, which was down 3304.03% from $46.7 million recorded in Q3 2025.
  • In the past 5 years, Medifast's Total Current Liabilities registered a high of $188.2 million during Q2 2022, and its lowest value of $43.0 million during Q4 2025.
  • In the last 5 years, Medifast's Total Current Liabilities had a median value of $112.5 million in 2023 and averaged $111.4 million.
  • As far as peak fluctuations go, Medifast's Total Current Liabilities surged by 7709.95% in 2021, and later plummeted by 4141.05% in 2024.
  • Quarter analysis of 5 years shows Medifast's Total Current Liabilities stood at $169.8 million in 2021, then dropped by 17.04% to $140.9 million in 2022, then crashed by 34.49% to $92.3 million in 2023, then tumbled by 30.49% to $64.2 million in 2024, then tumbled by 33.04% to $43.0 million in 2025.
  • Its Total Current Liabilities was $43.0 million in Q4 2025, compared to $46.7 million in Q3 2025 and $46.2 million in Q2 2025.